Search for a report

NORTH AMERICA JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

NORTH AMERICA JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

The North America joint pain injections market is evaluated to develop with a CAGR of 8.69% over the forecast period of 2022 to 2030. Factors such as the rising demand for advanced therapeutic platforms for joint pain to enhance treatment outcomes, in addition to the increasing number of new product approvals as well as launches, are anticipated to augment the market growth of the region.

NORTH AMERICA JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

North America Market by Joint Type (Knee, Shoulder and Elbow, Hip, Foot and Ankle, Other Joint Types) Market by Injection Type (Hyaluronic Acid, Corticosteroid, Other Drugs) Market by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) by Geography

Request free sample

The North America joint pain injections market is evaluated to develop with a CAGR of 8.69% over the forecast period of 2022 to 2030. Factors such as the rising demand for advanced therapeutic platforms for joint pain to enhance treatment outcomes, in addition to the increasing number of new product approvals as well as launches, are anticipated to augment the market growth of the region.

north-america-joint-pain-injections-market

To learn more about this report, request a free sample copy

The North America joint pain injections market growth assessment constitutes the analysis of the United States and Canada. The United States is the largest market for joint pain injections across North America. The country’s market growth is attributed to the increasing production of generic pharmaceuticals, surging product developments, and the rising government support to enhance biopharmaceutical and pharmaceutical industries. Furthermore, the high incidence of orthopedic diseases, as well as orthopedic surgeries, have indirectly contributed to the market growth in the United States.

As per a report published by the United States Department of Health & Human Services in 2018, approximately 700,000 knee replacement surgeries are conducted in the country annually. Moreover, the number is anticipated to reach nearly 3.48 million surgeries every year by 2030. In addition to knee surgeries, the prevalence of hip replacement surgeries is also increasing in the United States’ geriatric population. As a result, these factors are expected to propel the joint pain injections market growth in North America during the forecasted years.

Anika Therapeutics Inc, headquartered in the United States, is a biomedical joint preservation company involved in offering integrated joint preservation and regenerative treatments. It focuses on providing orthopedic joint therapies and sports medicine with innovative technologies. The company also delivers a wide spectrum of treatments ranging from joint preservation and restoration to osteoarthritis pain management.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • PARENT MARKET ANALYSIS: ORTHOPEDIC PROCEDURES MARKET
      • KEY DRIVERS
        • BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
        • GROWING NUMBER OF SPORT INJURIES
        • PREVALENCE OF MUSCULOSKELETAL DISORDERS
      • KEY RESTRAINTS
        • HIGH COSTS OF JOINT REPAIR THERAPIES
        • SIDE EFFECTS ASSOCIATED WITH JOINT REPAIR INJECTIONS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON JOINT PAIN INJECTIONS MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • KEY BUYING CRITERIA
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    1. MARKET BY JOINT TYPE
      • KNEE
      • SHOULDER AND ELBOW
      • HIP
      • FOOT AND ANKLE
      • OTHER JOINT TYPES
    2. MARKET BY INJECTION TYPE
      • HYALURONIC ACID
      • CORTICOSTEROID
      • OTHER DRUGS
    3. MARKET BY DISTRIBUTION CHANNEL
      • HOSPITALS PHARMACIES
      • RETAIL PHARMACIES
      • OTHER DISTRIBUTION CHANNELS
    4. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ALLERGAN PLC (ACQUIRED BY ABBVIE)
        • ANIKA THERAPEUTICS INC
        • BIOVENTUS INC
        • CHUGAI PHARMACEUTICAL
        • FERRING PHARMACEUTICALS
        • FIDIA PHARMA USA INC
        • FLEXION THERAPEUTICS INC
        • ORTHOGENRX INC
        • PFIZER INC
        • SANOFI
        • SEIKAGAKU CORPORATION
        • SMITH & NEPHEW PLC
        • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
        • ZIMMER BIOMET HOLDINGS

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – JOINT PAIN INJECTIONS

    TABLE 2: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 4: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 6: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 8: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA JOINT PAIN INJECTIONS MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, IN 2021

    FIGURE 6: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY KNEE, 2022-2030 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY SHOULDER AND ELBOW, 2022-2030 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY HIP, 2022-2030 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY FOOT AND ANKLE, 2022-2030 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY OTHER JOINT TYPES, 2022-2030 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, IN 2021

    FIGURE 12: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY CORTICOSTEROID, 2022-2030 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY OTHER DRUGS, 2022-2030 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, IN 2021

    FIGURE 16: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY HOSPITALS PHARMACIES, 2022-2030 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY RETAIL PHARMACIES, 2022-2030 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2030 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 20: UNITED STATES JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 21: CANADA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY JOINT TYPE
      • KNEE
      • SHOULDER AND ELBOW
      • HIP
      • FOOT AND ANKLE
      • OTHER JOINT TYPES
    2. MARKET BY INJECTION TYPE
      • HYALURONIC ACID
      • CORTICOSTEROID
      • OTHER DRUGS
    3. MARKET BY DISTRIBUTION CHANNEL
      • HOSPITALS PHARMACIES
      • RETAIL PHARMACIES
      • OTHER DISTRIBUTION CHANNELS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now